Improving Clinical Outcomes For Second Hematopoietic Stem Cell Transplants For Thalassemia Major – Science Trends
Science Trends |
Improving Clinical Outcomes For Second Hematopoietic Stem Cell Transplants For Thalassemia Major
Science Trends Allogeneic stem cell transplant is the only cure for β Thalassemia Major, but even with a matched sibling donor transplant, graft rejection is an unfortunate but all-too-common complication that may occur in up to 30% of transplants. This is especially … |
